Flow cytometer based on spectrum technology
By using MPPC detectors and real-time adjustment of lasers in flow cytometry, the problems of weak signal and unstable laser power are solved, the signal acquisition accuracy and stability are improved, and the system cost is reduced, and more efficient Cell detection.
Patent Information
- Application Number
- CN202420390019.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-03-01
- Publication Date
- 2024-12-06
- Estimated Expiration
- 2034-03-01
AI Technical Summary
In existing flow cytometry, the signal collected by the detector is weak and unstable, and the laser power stability is poor, resulting in insufficient signal acquisition accuracy and stability.
Using a flow cytometer based on spectral technology, the fluorescence and side astigmatism signals are received using an MPPC detector, and the changes in excitation light are monitored in real time, and the laser is adjusted to maintain the power of excitation light. Combined with the liquid delivery system of the syringe pump, it improves signal acquisition. Accuracy and liquid stability.
It improves the accuracy and response speed of signal acquisition, ensures the stability of laser signals, reduces system costs, and improves the stability of the liquid circuit.
Smart Images

Figure CN222125047U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to cell detection, in particular to a flow cytometer based on spectral technology. Background Art
[0002] In existing flow cytometers, lasers are used to excite cells stained with fluorescent agents, and the cells emit fluorescence. The excited cell fluorescence signals are then collected and analyzed to obtain cell information for use in cell research. The shortcomings of this type of flow cytometer are:
[0003] 1. The signals collected by the detector are all weak signals. How to collect these weak signals with high precision is the main problem of spectral flow cytometer.
[0004] 2. Laser is used to excite cell fluorescence, but the laser power stability is poor, resulting in a lack of stability in subsequent signal acquisition. Utility Model Content
[0005] In order to solve the deficiencies in the above-mentioned prior art solutions, the utility model provides a flow cytometer based on spectral technology.
[0006] The purpose of this utility model is achieved through the following technical solutions:
[0007] A flow cytometer based on spectral technology, comprising a light source, a sheath liquid pool and a first detector, wherein the excitation light emitted by the light source is incident into the sheath liquid pool, and the first detector receives the forward scattered light of the excitation light on the cells in the sheath liquid pool; and further comprising:
[0008] A first MPPC detector, which is disposed on a side of the sheath fluid pool and is used to receive fluorescence excited by cells in the sheath fluid pool;
[0009] a second MPPC detector, the second MPPC detector being disposed at a side of the sheath liquid pool and configured to receive side scattered light of the excitation light on cells in the sheath liquid pool;
[0010] A first filter device and a second filter device, wherein the first filter device is arranged on a fluorescence light path between the sheath fluid pool and the first MPPC detector, and the second filter device is arranged on a side scattered light path between the sheath fluid pool and the second MPPC detector.
[0011] Compared with the prior art, the utility model has the following beneficial effects:
[0012] 1.Stable signal acquisition;
[0013] The MPPC detector is used to collect fluorescence and side scattered light signals, which has higher gain and sensitivity than the existing APD and other technologies, and improves the system signal collection accuracy and response speed;
[0014] 2. The laser signal is stable;
[0015] The second detector is used to monitor the changes in the intensity of the excitation light in real time, and the laser is adjusted in real time through the driving circuit to stabilize the excitation light power to the microwatt level, making the system acquisition accuracy higher and more stable;
[0016] 3. Good liquid stability;
[0017] Using a syringe pump to absorb sample gas and transport samples has lower costs than the vacuum pump liquid circuit system of the prior art, but has the same liquid circuit stability effect. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] The disclosure of the present invention will become easier to understand with reference to the accompanying drawings. It is easy for those skilled in the art to understand that these drawings are only used to illustrate the technical solution of the present invention and are not intended to limit the scope of protection of the present invention. In the drawings:
[0019] Figure 1 It is a schematic diagram of the structure of a flow cytometer based on spectral technology according to an embodiment of the utility model. DETAILED DESCRIPTION
[0020] Figure 1 The following description describes optional specific embodiments of the present invention to teach those skilled in the art how to implement and reproduce the present invention. In order to explain the technical solution of the present invention, some conventional aspects have been simplified or omitted. Those skilled in the art should understand that variations or substitutions derived from these specific embodiments will be within the scope of the present invention. Those skilled in the art should understand that the following features can be combined in various ways to form multiple variations of the present invention. Thus, the present invention is not limited to the following optional specific embodiments, but is only limited by the claims and their equivalents.
[0021] Example 1
[0022] Figure 1 The structure diagram of the flow cytometer based on spectral technology of the embodiment of the utility model is schematically given, as shown in FIG. Figure 1 As shown, the spectral technology-based flow cytometer comprises:
[0023] A light source 12, a sheath liquid pool 21 and a first detector 31, wherein the excitation light emitted by the light source 12 is incident into the sheath liquid pool 21, and the first detector 31 receives the forward scattered light of the excitation light on the cells in the sheath liquid pool 21;
[0024] A first MPPC detector 41, which is disposed at a side of the sheath liquid pool 21 and is used to receive fluorescence excited by cells in the sheath liquid pool 21;
[0025] A second MPPC detector 42, which is disposed at a side of the sheath liquid pool 21 and is used to receive side scattered light of the excitation light on cells in the sheath liquid pool 21;
[0026] The first filter device 43 and the second filter device 44 are arranged on the fluorescence light path between the sheath liquid pool 21 and the first MPPC detector 41 , and the second filter device 44 is arranged on the side scattered light path between the sheath liquid pool 21 and the second MPPC detector 42 .
[0027] In order to stabilize the intensity of the excitation light, the flow cytometer based on spectral technology further includes:
[0028] A beam splitter 14, the beam splitter 14 is used to split the excitation light of the light source into a first light beam and a second light beam, the first light beam passes through the sheath liquid pool 21;
[0029] The second detector 32 receives the second light beam.
[0030] In order to reduce costs and provide working stability, further, the beam splitter 14 is a transflective mirror, the first light beam is reflected light, and the second light beam is transmitted light.
[0031] In order to make the cells pass through the sheath fluid pool one by one, the flow cytometer based on spectral technology further includes a sample injection unit, which includes:
[0032] A sampling tube 71, a sampling tube 72 and a first pump 61, wherein the sampling tube 71 is arranged on a guide rail and moves up and down under the drive; the first pump 61 is connected to the sampling tube 71 and the sampling tube 72 respectively, and the output end of the sampling tube 72 is connected to the sheath liquid pool;
[0033] The second pump 62 is used to deliver the sheath liquid into the sheath liquid tank 21 .
[0034] In order to reduce the cost of the device, further, the first pump 61 is a syringe pump, and the injection unit further includes:
[0035] The switching module 51 is used to enable the injection pump to selectively connect the sampling tube 71 and the injection tube 72 .
[0036] In order to increase the fluorescence intensity and thus improve the detection sensitivity, the flow cytometer based on spectral technology further includes:
[0037] The lens group 13 , after passing through the lens group 13 , the excitation light is focused in the sheath liquid pool 21 .
[0038] Example 2
[0039] An application example of a flow cytometer based on spectral technology according to Example 1 of the utility model.
[0040] In this application example, Figure 1 As shown, the light source 12 uses a semiconductor laser, and under the action of its driving circuit 11, it emits excitation light, and the light intensity is adjustable. The excitation light passes through the beam splitter 14 and is divided into a transmitted second light beam and a reflected first light beam. The beam splitter 14 uses a transflective mirror with a reflectivity of 95%. After being shaped by the lens group 13, the first light beam converges on the central axis of the sheath liquid pool 21;
[0041] The first detector 31 adopts PD to receive the forward scattered light of the excitation light; the first filter and the first MPPC detector 41 are arranged on the side of the sheath liquid pool 21, and the central axis is perpendicular to the central axis of the first light beam. The second filter and the second MPPC detector 42 are arranged on the side of the sheath liquid pool 21, and the angle between the central axis and the central axis of the first light beam is an acute angle, that is, the first detector 31, the second MPPC detector 42 and the first MPPC detector 41 are arranged in sequence in the counterclockwise direction. The second detector 32 adopts PD to receive the second light beam.
[0042] In the injection unit, the injection pump is connected to the first port of the electromagnetic three-way valve, and the sampling tube 71 and the injection tube 72 are connected to the second port and the third port of the electromagnetic three-way valve respectively. By switching, the first port is selectively connected to the second port and the third port. The sampling tube 71 is set on the vertical guide rail and enters the sample or exits the sample cup under the drive. The peristaltic pump is connected to the sheath liquid container and the sheath liquid pool 21.
[0043] The working mode of the flow cytometer based on spectral technology in this embodiment is as follows:
[0044] The laser emits excitation light, which is then divided into a first light beam and a second light beam. The second light beam is received by the second detector 32 to monitor the intensity change of the excitation light in real time. If the intensity change exceeds a threshold, the driving circuit 11 is used to adjust the excitation light to keep the intensity of the excitation light stable.
[0045] After being shaped by the lens group 13, the second light beam is focused on the central axis of the sheath liquid pool 21, and excites the stained cells to emit fluorescence. The fluorescence passes through the first filter and is received by the first MPPC detector 41. The side scattered light passes through the second filter and is received by the second MPPC detector 42. The forward scattered light is received by the first detector 31.
[0046] The analysis unit analyzes the output signals of the first detector 31, the first MPPC detector 41 and the second MPPC detector 42 to obtain cell information. The specific analysis method is the prior art in the art.
Claims
1. A flow cytometer based on spectral technology, comprising a light source, a sheath fluid pool and a first detector, wherein the excitation light emitted by the light source is incident into the sheath fluid pool, and the first scattered light is received by the first detector as the forward scattered light of the excitation light on the cells in the sheath fluid pool; characterized in that: The spectral technology-based flow cytometer also includes: A first MPPC detector, which is disposed on a side of the sheath fluid pool and is used to receive fluorescence excited by cells in the sheath fluid pool; a second MPPC detector, the second MPPC detector being disposed at a side of the sheath liquid pool and configured to receive side scattered light of the excitation light on cells in the sheath liquid pool; A first filter device and a second filter device, wherein the first filter device is arranged on a fluorescence light path between the sheath liquid pool and the first MPPC detector, and the second filter device is arranged on a side scattered light path between the sheath liquid pool and the second MPPC detector.
2. The spectral technology-based flow cytometer according to claim 1, characterized in that: The spectral technology-based flow cytometer also includes: A beam splitter, the beam splitter is used to split the excitation light of the light source into a first light beam and a second light beam, the first light beam passing through the sheath fluid pool; A second detector is provided, wherein the second detector receives the second light beam.
3. The spectral technology-based flow cytometer according to claim 2, characterized in that: The beam splitter is a transflective mirror, the first light beam is reflected light, and the second light beam is transmitted light.
4. The spectral technology-based flow cytometer according to claim 1, characterized in that: The flow cytometer based on spectral technology also includes a sample injection unit, which includes: A sampling tube, a sampling tube and a first pump, wherein the sampling tube is arranged on a guide rail and moves up and down under the drive; the first pump is connected to the sampling tube and the sampling tube respectively, and the output end of the sampling tube is connected to the sheath liquid pool; A second pump is used to deliver sheath fluid into the sheath fluid tank.
5. The spectral technology-based flow cytometer according to claim 4, characterized in that: The first pump is a syringe pump, and the injection unit further comprises: A switching module is used to enable the injection pump to selectively connect the sampling tube and the injection tube.
6. The spectral technology-based flow cytometer according to claim 4, characterized in that: The second pump is a peristaltic pump.
7. The spectral technology-based flow cytometer according to claim 1, characterized in that: The light source is a laser and its driving circuit, and the first detector is a PD.
8. The spectral technology-based flow cytometer according to claim 1, characterized in that: The spectral technology-based flow cytometer also includes: A lens group, after the excitation light passes through the lens group, it is focused in the sheath fluid pool.
